Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands

Abstract The world is combating an ongoing COVID-19 pandemic with health-care systems, society and economies impacted in an unprecedented way. It is unclear how many people have contracted the causative coronavirus (SARS-CoV-2) unknowingly and are asymptomatic. Therefore, reported COVID-19 cases do not reflect the true scale of outbreak. Here we present the prevalence and distribution of antibodies to SARS-CoV-2 in a healthy adult population of the Netherlands, which is a highly affected country, using a high-performance immunoassay. Our results indicate that one month into the outbreak (i) th... Mehr ...

Verfasser: Slot, Ed
Hogema, Boris M.
Reusken, Chantal B. E. M.
Reimerink, Johan H.
Molier, Michel
Karregat, Jan H. M.
IJlst, Johan
Novotný, Věra M. J.
van Lier, René A. W.
Zaaijer, Hans L.
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Reihe/Periodikum: Nature Communications ; volume 11, issue 1 ; ISSN 2041-1723
Verlag/Hrsg.: Springer Science and Business Media LLC
Schlagwörter: General Physics and Astronomy / General Biochemistry / Genetics and Molecular Biology / General Chemistry / Multidisciplinary
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27236727
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1038/s41467-020-19481-7

Abstract The world is combating an ongoing COVID-19 pandemic with health-care systems, society and economies impacted in an unprecedented way. It is unclear how many people have contracted the causative coronavirus (SARS-CoV-2) unknowingly and are asymptomatic. Therefore, reported COVID-19 cases do not reflect the true scale of outbreak. Here we present the prevalence and distribution of antibodies to SARS-CoV-2 in a healthy adult population of the Netherlands, which is a highly affected country, using a high-performance immunoassay. Our results indicate that one month into the outbreak (i) the seroprevalence in the Netherlands was 2.7% with substantial regional variation, (ii) the hardest-hit areas showed a seroprevalence of up to 9.5%, (iii) the seroprevalence was sex-independent throughout age groups (18–72 years), and (iv) antibodies were significantly more often present in younger people (18–30 years). Our study provides vital information on the extent of exposure to SARS-CoV-2 in a country where social distancing is in place.